Immunology and Microbiology
Adaptive Immune System
11%
Antibody Response
37%
Autoimmune Disease
8%
BK Virus
11%
Blood Plasma
64%
Breakthrough Infection
10%
CD4 Lymphocyte Count
19%
Cell Culture
12%
Cerebrospinal Fluid
8%
Chemokine
8%
Coinfection
11%
COVID-19
61%
Cytokine
11%
Epstein Barr Virus
29%
Hepatitis B Virus
17%
Hepatitis C Virus
14%
Human Cytomegalovirus
8%
Human Herpesvirus 8
8%
Human Immunodeficiency Virus
53%
Human Immunodeficiency Virus 1
62%
Human Immunodeficiency Virus Infection
10%
Human Immunodeficiency Virus Type 1 Subtype C
10%
Immune Response
15%
Immunocompromised Patient
17%
Immunosuppression
12%
Inflammatory Arthritis
13%
JC Virus
8%
Macrophage Inflammatory Protein
8%
Maturation
8%
Metagenomic Next-Generation Sequencing
8%
Monospecific Antibody
17%
Neutralization
10%
Neutralizing Antibody
24%
Omicron Coronavirus Variant
44%
Peripheral Blood Mononuclear Cell
9%
Real Time Polymerase Chain Reaction
11%
Reverse Transcriptase
10%
Seropositivity
8%
Seroprevalence
11%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
15%
T Cell
13%
Titer
16%
Toxoplasmosis
8%
Vaccination Policy
15%
Vaccine Efficacy
21%
Viral Disease
27%
Viral Load
43%
Virus
10%
Virus Infectivity
23%
Keyphrases
Antibody Level
14%
Antibody Response
26%
Antiretroviral Prophylaxis
8%
Antiretroviral Therapy
10%
CD4 Count
9%
Cell Culture
11%
Co-infection
11%
Combivir
8%
Convalescent Plasma
16%
COVID-19
45%
COVID-19 mRNA Vaccine
8%
COVID-19 Vaccine
9%
Delta Variant
8%
Drug-resistant Variant
10%
EBNA1
11%
Epstein-Barr Virus
16%
Epstein-Barr Virus Infections
8%
Gastric Adenocarcinoma
8%
Genomic Surveillance
10%
Healthy Controls
15%
Healthy Individuals
8%
Hepatitis B Virus
17%
HIV Patients
12%
HIV Viral Load
11%
Hospitalization
12%
Human Immunodeficiency Virus Type 1 (HIV-1)
67%
Immune Response
12%
Immunocompromised Patients
13%
India
29%
Infected Individual
39%
Infectious Virus
18%
Nave
20%
Neurotropic Virus
8%
Omicron Variant
13%
Peripheral Blood Mononuclear Cells
9%
Plasma Viral Load
11%
PMTCT
8%
Pregnant Women
17%
SARS-CoV-2 Infection
10%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
12%
South India
35%
Tertiary Care Hospital
17%
Uganda
8%
Unvaccinated
16%
Variants of Concern
13%
Viral
11%
Viral Kinetics
12%
Viral Load
12%
Virus
11%
Virus Diseases
10%